Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record.

What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium steering committee

Open access
Harper, J., Coonen, E., De Rycke, M., Fiorentino, F., Geraedts, J., Goossens, V., Harton, G., Moutou, C., Pehlivan Budak, T., Renwick, P., SenGupta, S., Traeger-Synodinos, J., Vesela, K.·2010·Human Reproduction

Abstract

Since 2004, there have been 11 randomized controlled trials (RCTs) mainly for advanced maternal age (AMA), which have shown no benefit of performing preimplantation genetic screening (PGS). Ten of the RCTs have been performed at the cleavage stage and one at the blastocyst stage. It is probable that the high levels of chromosomal mosaicism at cleavage stages, which may result in the tested cell not being representative of the embryo, and the inability to examine all of the chromosomes using fluorescence in situ hybridization, have contributed to the lack of positive outcome from the RCTs. We suggest that future RCTs should examine alternative biopsy timing (polar body and/or trophectoderm biopsy), and should apply technologies that allow more comprehensive testing to include all chromosomes (microarray-based testing) to determine if PGS shows an improvement in delivery rate. Currently there is no evidence that routine PGS is beneficial for patients with AMA and conclusive data (RCTs) on repeated miscarriage, implantation failure and severe male factor are missing. To evaluate benefits of PGS, an ESHRE trial has recently been started on patients with AMA using polar body biopsy and array-comparative genomic hybridization, which should bring more information on this patient group in the near future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/dep476

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 217

Metadata

Authors
Harper, J., Coonen, E., De Rycke, M., Fiorentino, F., Geraedts, J., Goossens, V., Harton, G., Moutou, C., Pehlivan Budak, T., Renwick, P., SenGupta, S., Traeger-Synodinos, J., & Vesela, K.
Venue
Human Reproduction
Published
2010-02-02
Volume
25
Issue
4
Pages
821-823
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2151661502
Cited by
217
References
0
FWCI
32.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium steering committee. https://app.cochat.ai/papers/10.1093/humrep/dep476
The paper
Harper, J., Coonen, E., De Rycke, M., Fiorentino, F., Geraedts, J., Goossens, V., Harton, G., Moutou, C., Pehlivan Budak, T., Renwick, P., SenGupta, S., Traeger-Synodinos, J., & Vesela, K. (2010). What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium steering committee. Human Reproduction. https://doi.org/10.1093/humrep/dep476

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.